Evaxion significantly expands vaccine development collaboration with MSD
September 26, 2024 07:30 ET
|
Evaxion Biotech
Agreement provides MSD with options to license Evaxion’s preclinical, AI-designed vaccine candidates EVX-B2 and EVX-B3Evaxion will host a conference call and webcast to discuss the agreement on...